As pharma realizes the value of becoming more patient-centric, aligning HCP and DTC brand marketing to the patient journey becomes pivotal. In this MM+M #TrendTalks session, “What does it really take ...
Direct-to-consumer (DTC) advertising of pharmaceuticals is a controversial topic within healthcare and psychiatry, with only ...
In 2023, pharma became the second-largest industry for ad spending in the US, with top brands spending millions each month on T.V. commercials alone. And that’s before considering the spend on other ...
Media investments influencing news coverage. Governmental agencies plagued by commercial incentives. The adulteration of medicine. All are criticisms leveled by Robert F. Kennedy Jr., President-Elect ...
Are you a print subscriber? Activate your account. By Tim Nudd - 15 min 9 sec ago By Erika Wheless - 25 min 9 sec ago By Gillian Follett - 25 min 9 sec ago By Eric Mayhew - 39 min 36 sec ago By Tim ...
Are you a print subscriber? Activate your account. By Erika Wheless - 3 min 42 sec ago By Brian Bonilla - 57 min 10 sec ago By Tim Nudd - 1 hour 26 min ago By Jon Springer - 3 hours 57 min ago By ...
DTC brands made a name for themselves as high-performance marketers through direct response campaigns on social platforms, especially Facebook. They were laser-focused on performance, identifying the ...
SAN DIEGO and NEW YORK, Nov. 23, 2021 /PRNewswire/ -- The international provider of insight-led customer experiences, Mapp, and the world's fastest-growing commerce platform, VTEX, are launching the ...
In the final part of his conversation with Pharmaceutical Executive, Sandy Donaldson discusses the challenges that pharma faces when marketing direct-to-consumers. Sandy Donaldson, co-founder and ...
The Web is king to pharma who are focusing more attention on building relationships with consumers, according to Cegedim Dendrite's latest DTC Industry Check-Up Survey. According to the annual survey, ...
Leo Pharma has decided “It’s GO time” for the launch of its JAK inhibitor cream Anzupgo. Having built its growth plans on the recently approved medicine, the Danish drugmaker is running a ...